6CM
683 Capital Management Portfolio holdings
AUM
$1.2B
1-Year Est. Return
91.89%
This Fund
S&P 500
1 Year Est. Return
+91.89%
AUM
$1.1B
AUM Growth
+$115M
(+12%)
Holding
155
Top Buys
| 1 | +$15.4M | |
| 2 | +$14.9M | |
| 3 | +$13.6M | |
| 4 |
TG Therapeutics
TGTX
|
+$10.7M |
| 5 |
Porch Group
PRCH
|
+$6.9M |
Top Sells
| 1 | +$15.8M | |
| 2 | +$10.5M | |
| 3 | +$10M | |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$9.28M |
| 5 |
Centene
CNC
|
+$9.23M |
Sector Composition
| 1 | Healthcare | 39.18% |
| 2 | Financials | 13.59% |
| 3 | Consumer Discretionary | 12.33% |
| 4 | Industrials | 7.75% |
| 5 | Technology | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNDK
26
Sandisk
SNDK
$91.3B
| $11.9M | 1.08% |
106,000
-26,000
|
|
||
|
27
TG Therapeutics
TGTX
$4.67B
| $11.7M | 1.07% |
+325,000
|
|
||
28
IAMGOLD
IAG
$13.1B
| $11.6M | 1.06% |
900,000
+390,000
|
|
||
29
ASML
ASML
$533B
| $10.6M | 0.97% |
11,000
-3,650
|
|
||
30
Inspired Entertainment
INSE
$213M
| $10.6M | 0.96% |
1,125,000
-240,000
|
|
||
|
MREO
31
Mereo BioPharma
MREO
$63.6M
| $10M | 0.91% |
4,875,000
+525,000
|
|
||
32
Lennar Class A
LEN
$24.4B
| $9.96M | 0.9% |
79,000
|
|
||
33
Zevra Therapeutics
ZVRA
$623M
| $9.27M | 0.84% |
975,000
-150,000
|
|
||
|
XHR
34
Xenia Hotels & Resorts
XHR
$1.37B
| $8.85M | 0.8% |
645,000
-245,000
|
|
||
|
ARIS
35
Aris Mining
ARIS
$4.08B
| $8.82M | 0.8% |
900,000
-600,000
|
|
||
36
Alphabet (Google) Class A
GOOGL
$3.71T
| $8.75M | 0.8% |
36,000
|
|
||
37
Western Alliance Bancorporation
WAL
$7.94B
| $8.67M | 0.79% |
100,000
-17,500
|
|
||
38
Harmony Biosciences
HRMY
$1.66B
| $7.77M | 0.71% |
282,000
-20,000
|
|
||
|
39
Porch Group
PRCH
$812M
| $7.55M | 0.69% |
+450,000
|
|
||
40
Fractyl Health
GUTS
$74.6M
| $7.39M | 0.67% |
4,650,000
+4,005,000
|
|
||
41
Invivyd
IVVD
$516M
| $6.93M | 0.63% |
6,300,000
+3,230,000
|
|
||
|
TVRD
42
Tvardi Therapeutics
TVRD
$35.9M
| $6.77M | 0.61% |
176,030
|
|
||
43
Amicus Therapeutics
FOLD
$4.51B
| $6.58M | 0.6% |
835,000
-125,000
|
|
||
44
Apellis Pharmaceuticals
APLS
$2.51B
| $6.52M | 0.59% |
288,000
-122,000
|
|
||
45
Bristow Group
VTOL
$1.34B
| $6.32M | 0.57% |
175,300
+87,167
|
|
||
46
Viking Therapeutics
VKTX
$4.01B
| $6.31M | 0.57% |
240,000
-14,000
|
|
||
47
Lexeo Therapeutics
LXEO
$526M
| $6.13M | 0.56% |
+922,662
|
|
||
48
Seadrill
SDRL
$2.68B
| $6.04M | 0.55% |
200,000
-15,000
|
|
||
49
Amazon
AMZN
$2.3T
| $5.82M | 0.53% |
26,500
-1,500
|
|
||
50
Elevance Health
ELV
$62.4B
| $5.82M | 0.53% |
18,000
-7,000
|
|